Barbara De Filippis | Pharmaceutical Chemistry | Women Researcher Award

Published on by World Top Scientists

Assoc. Prof. Dr. Barbara De Filippis | Pharmaceutical Chemistry | Women Researcher Award

Associate Professor | University of G. d’Annunzio Chieti and Pescara | Italy

Assoc. Prof. Dr. Barbara De Filippis is an accomplished scholar in pharmaceutical chemistry whose career reflects sustained excellence in research, teaching, and scientific leadership. With a rigorous academic foundation in pharmaceutical sciences supported by advanced research qualifications, she has cultivated deep expertise in the design, synthesis, and evaluation of bioactive molecules. Her professional trajectory includes extensive experience in academic research environments, where she has contributed to and coordinated laboratory activities, guided research teams, and played a central role in advancing innovative scientific projects. Her work spans molecular design, medicinal chemistry, and pharmaceutical analysis, contributing to the development of compounds with potential therapeutic relevance. She has been an active participant in national and international research collaborations, integrating multidisciplinary approaches that strengthen the impact and visibility of her scientific contributions. Her publication record, comprising numerous peer-reviewed articles indexed in leading scientific databases, is supported by a robust citation profile and a significant h-index, underscoring both productivity and influence within the research community. She has consistently demonstrated commitment to high-quality scholarship through ongoing contributions to the scientific literature, active engagement in research networks, and participation in scholarly dissemination. Her career is further distinguished by professional recognitions and academic qualifications that affirm her disciplinary expertise and long-standing dedication to pharmaceutical chemistry. Through her combined strengths in research innovation, academic service, and collaborative leadership, Assoc. Prof. Dr Barbara De Filippis exemplifies the profile of an outstanding researcher whose continued work promises further advancements in medicinal chemistry and related scientific fields.

Profiles: Scopus | ORCID

Featured Publications

1. Kazimierczak, P., Balaha, M., Palka, K., Wessely-Szponder, J., Wojcik, M., di Giacomo, V., De Filippis, B., & Przekora, A. (2025). Macroporous hydroxyapatite-based bone scaffolds loaded with CAPE derivatives: A strategy to reduce oxidative stress and biofilm formation. Materials, 18.

2. De Filippis, B., Agamennone, M., Ammazzalorso, A., Amoroso, R., Giampietro, L., Maccallini, C., Sağlık, B. N., De Simone, C., Zuccarini, M., Kaplancıklı, Z. A., et al. (2025). Discovery and evaluation of novel sulfonamide derivatives targeting aromatase in ER+ breast cancer. Pharmaceuticals, 18.

3. De Filippis, B., Della Valle, A., Ammazzalorso, A., Maccallini, C., Tesse, G., Amoroso, R., Mollica, A., & Giampietro, L. (2024). Azobenzene as multi-targeted scaffold in medicinal chemistry. Molecules, 29.

4. Tesse, G., Tolomeo, A., De Filippis, B., & Giampietro, L. (2024). Radiolabeled probes from derivatives of natural compounds used in nuclear medicine. Molecules, 29.

5. Maccallini, C., Budriesi, R., De Filippis, B., & Amoroso, R. (2024). Advancements in the research of new modulators of nitric oxide synthases activity. International Journal of Molecular Sciences, 25.

Assoc. Prof. Dr Barbara De Filippis advances scientific innovation through the design and development of novel pharmaceutical compounds that address critical therapeutic needs and strengthen translational research. Her contributions enhance drug discovery processes, support healthier societies, and foster meaningful progress in medicinal chemistry with potential global impact.

Zaid Khan | Clinical Pharmacist | Young Researcher Award

Published on by World Top Scientists

Dr. Zaid Khan | Clinical Pharmacist | Young Researcher Award

Zaid Khan | Aditya Bangalore Institute of Pharmacy Education and Research | India

Dr. Zaid Khan is a dedicated and emerging researcher in pharmaceutical sciences with a Doctor of Pharmacy background. He has gained valuable clinical and research experience through internships in reputed hospitals and research institutions, where he contributed to projects involving antibiotic prophylaxis, medication therapy management, and pain management. His work demonstrates strong analytical, clinical, and research design skills, complemented by effective communication and patient counseling abilities. Dr. Khan has published and presented research at national and international platforms and actively engages in professional development through workshops and conferences. His achievements, including recognition as a Young Researcher Award recipient, reflect his commitment to advancing clinical pharmacy and drug safety practices. With a strong interest in bridging research and clinical application, Dr. Khan aspires to contribute to innovative therapeutic strategies, pharmacovigilance, and evidence-based healthcare, positioning himself as a promising professional in the evolving field of pharmaceutical research.

Profiles: Google Scholar | ORCID

Featured Publications

1. Khan, Z., Krishna, D., Daga, S., Rastogih, N., Rekha, M., & Patel, K. (2023). Advancements in minimally invasive surgery: A comprehensive analysis of robotic surgery, endoscopic techniques, and natural orifice translumenal endoscopic surgery. Georgian Medical News, 87–92.

2. Khan, Z., Rekha, M. M., Hiremath, S. R. R., & Shapur, S. R. (2025). A comprehensive study on antibiotic prophylaxis practices across diverse surgical modalities. Journal of Pharmaceutical Care, 93–100.

3. Khan, Z., Ramya, C. V., PR, D. S., & Vishwanath, B. A. (2025). Development and computational analysis of polyherbal chewable lozenges for effective management of mouth and throat infections. Palestinian Medical and Pharmaceutical Journal.

4. Khan, Z. (2024). A case report of advanced periampullary carcinoma: Palliative chemotherapy following Whipple’s surgery. Research & Reviews: Journal of Oncology and Hematology, 13.

5. Zaid, K., & Khan, Z. (2023). Beyond chemotherapy: The promise of immunotherapy in cancer care and advancements in cancer therapy. Research & Reviews: A Journal of Immunology, 13(2), 22–37.

Sireen Abdulrahim Shilbayeh | Clinical Pharmacy | Best Researcher Award

Published on by World Top Scientists

Prof. Sireen Abdulrahim Shilbayeh | Clinical Pharmacy | Best Researcher Award

Professor at Princess Nora University, Pharmacy College, Riyadh, Saudi Arabia

Professor Sireen Abdulrahim Shilbayeh is a distinguished academic in clinical pharmacy with over two decades of experience in teaching, research, and healthcare practice. She earned her Ph.D. in Clinical Pharmacy Practice from the University of Nottingham, UK, specializing in pharmaceutical and health outcomes research, particularly the meta-analysis of antiarrhythmic drug trials. Currently a professor at Princess Nourah University in Riyadh, Saudi Arabia, she has held several key academic and administrative roles, including department head and scientific committee member. Her core strengths include evidence-based clinical practice, curriculum development, and interprofessional collaboration. She has been recognized with multiple institutional awards for research excellence and productivity. Her scholarly contributions span clinical trials, systematic reviews, and pharmacy education, supported by active participation in international conferences. Professor Shilbayeh is committed to advancing pharmacy practice through impactful research, academic leadership, and the mentoring of future healthcare professionals.

🔹Professional Profile 

Google Scholar
Scopus Profile 

🏆Strengths for the Award

Professor Shilbayeh demonstrates a distinguished and consistent record of academic and research achievements. Her doctoral training from the University of Nottingham, UK, focused on high-impact, evidence-based clinical pharmacy research, particularly in meta-analysis and systematic reviews—areas that are fundamental to improving clinical decision-making and healthcare outcomes.

Her long-standing academic trajectory, progressing from Assistant to Full Professor, across multiple universities, reflects both resilience and recognition of her scholarly contributions. She has served in prestigious roles, including chair memberships in university scientific councils and IRB committees, indicating peer trust and leadership in research governance.

Further, she has received multiple awards for research excellence from Princess Nourah University, particularly for prolific output in health sciences—a strong testament to her research productivity and impact. Her work on antiarrhythmic drug evaluations and pharmacoepidemiology, combined with over two decades of conference participation, showcases her dedication to scientific dissemination and continuing professional development.

🎓 Education

Professor Sireen Abdulrahim Shilbayeh holds a strong academic foundation in pharmaceutical sciences. She began her studies at King Saud University in Riyadh, Saudi Arabia, where she earned her Bachelor’s degree in Pharmacy. Seeking to further her education, she pursued postgraduate studies at the University of Nottingham in the United Kingdom. There, she completed an MPhil in Clinical Pharmacy, focusing on systematic reviews of clinical trials, followed by a Ph.D. in Clinical Pharmacy Practice. Her doctoral research specialized in the meta-analysis of randomized clinical trials involving antiarrhythmic drugs, combining rigorous scientific methodology with practical clinical implications. Throughout her academic journey, she developed a comprehensive understanding of clinical pharmacy, pharmacoepidemiology, and pharmaceutical care. Her education has been instrumental in shaping her evidence-based research approach, teaching philosophy, and ability to lead complex projects in academia and healthcare. These qualifications have paved the way for her successful academic and professional career in the region and beyond.

💼 Experience

Professor Shilbayeh brings over 25 years of academic and clinical experience in pharmacy. She began her professional career as a pharmacist at King Khaled University Hospital in Riyadh, gaining hands-on experience in inpatient and outpatient services, IV preparation, and drug information. She later worked as a clinical researcher at Nottingham University Hospital, focusing on cardiovascular pharmacotherapy. Her academic journey includes positions at Applied Science University and Al-Zytoonah University in Jordan, where she progressed from Assistant to Associate Professor. Since 2010, she has been affiliated with Princess Nourah University, where she became a Full Professor in 2015. Beyond teaching, she has served in several administrative capacities, including Head of the Clinical Pharmacy Practice Department, and as a member of the Institutional Review Board, Scientific Council, and Development Committees. Her career is marked by a blend of teaching excellence, research leadership, and a commitment to advancing clinical pharmacy education and healthcare practices.

🏅Awards and Honors

Professor Sireen Shilbayeh has received multiple accolades recognizing her contributions to research and academia. Among her most notable honors is the Excellence in Research Productivity Award from Princess Nourah University, awarded across all health-related faculties. This prestigious recognition highlights her extensive research output and impact within the healthcare sector. Additionally, she received an Appreciation Award from the University’s Graduate and Research Agency for her distinguished publications in indexed international journals. These awards reflect her dedication to scholarly excellence, continuous engagement with high-quality research, and leadership within the academic community. Her ability to maintain consistent output while supporting academic development and policy initiatives has earned her widespread respect. These honors also serve as acknowledgment of her commitment to raising standards in pharmacy practice and education, both regionally and internationally. Her achievements continue to inspire colleagues and students, solidifying her reputation as a leading figure in clinical pharmacy research.

🔬 Research Focus on Clinical Pharmacy

Professor Shilbayeh’s research centers on clinical pharmacy practice, with a strong emphasis on evidence-based medicine, pharmaceutical care, and health outcomes research. Her early work, including her doctoral dissertation, focused on the meta-analysis of antiarrhythmic drug trials, contributing valuable insights into cardiology-related pharmacotherapy. She is deeply involved in systematic reviews, pharmacoepidemiology, and comparative effectiveness research, ensuring her findings have direct clinical relevance. Her scholarly interests also span patient-centered care, drug safety, and therapeutic decision-making, aiming to improve the quality and efficiency of healthcare delivery. She frequently collaborates on projects addressing chronic disease management and clinical interventions in pharmacy practice. Through her work on the Institutional Review Board, she contributes to research ethics and the development of robust study designs. Her research not only informs clinical practice but also plays a key role in curriculum development and training for future pharmacists, emphasizing scientific rigor and real-world application.

📚 Publications Top Notes

  • Title: Prevalence of osteoporosis and its reproductive risk factors among Jordanian women: a cross-sectional study
    Authors: S. Shilbayeh
    Year: 2003
    Citations: 114

  • Title: Exploring knowledge and attitudes towards counselling about vitamin supplements in Jordanian community pharmacies
    Authors: S.A. Shilbayeh
    Year: 2011
    Citations: 42

  • Title: Validation of knowledge and adherence assessment tools among patients on warfarin therapy in a Saudi hospital anticoagulant clinic
    Authors: S.A.R. Shilbayeh, W.A. Almutairi, S.A. Alyahya, N.H. Alshammari, E. Shaheen, et al.
    Year: 2018
    Citations: 40

  • Title: University students’ knowledge, attitudes, and practices towards the national premarital screening program of Saudi Arabia
    Authors: M. Melaibari, S. Shilbayeh, A. Kabli
    Year: 2017
    Citations: 35

  • Title: Does COVID-19 lockdowns have impacted on global dengue burden? A special focus to India
    Authors: H. Sharma, A. Ilyas, A. Chowdhury, N.K. Poddar, A.A. Chaudhary, et al.
    Year: 2022
    Citations: 29

  • Title: The impact of CYP3A5 and MDR1 polymorphisms on tacrolimus dosage requirements and trough concentrations in pediatric renal transplant recipients
    Authors: S. Shilbayeh, R. Zmeili, R.I. Almardini
    Year: 2013
    Citations: 22

  • Title: A Markov Chain Model to Evaluate the Effect of CYP3A5 and ABCB1 Polymorphisms on Adverse Events Associated with Tacrolimus in Pediatric Renal Patients
    Authors: S.K.B. Sy, J. Heuberger, S. Shilbayeh, D.J. Conrado, H. Derendorf
    Year: 2013
    Citations: 19

  • Title: Pediatric renal transplantation in the Jordanian population: the clinical outcome measures during long-term follow-up period
    Authors: S. Shilbayeh, I. Hazza
    Year: 2012
    Citations: 17

  • Title: Quantitation of the impact of CYP3A5 A6986G polymorphism on quetiapine pharmacokinetics by simulation of target attainment
    Authors: S.A.R. Shilbayeh, S.K.B. Sy, M. Melhem, R. Zmeili, H. Derendorf
    Year: 2015
    Citations: 14

  • Title: Possible interethnic differences in omeprazole pharmacokinetics: comparison of Jordanian Arabs with other populations
    Authors: S. Shilbayeh, M.F. Tutunji
    Year: 2006
    Citations: 14

  • Title: Treatment satisfaction questionnaire for medication: validation of the translated Arabic version among patients undergoing warfarin therapy in Saudi Arabia
    Authors: S.A.R. Shilbayeh, S.A. Alyahya, N.H. Alshammari, W.A. Almutairi, E. Shaheen
    Year: 2018
    Citations: 10

  • Title: The impact of genetic polymorphisms on time required to attain the target tacrolimus levels and subsequent pharmacodynamic outcomes in pediatric kidney transplant patients
    Authors: S. Shilbayeh
    Year: 2014
    Citations: 10

  • Title: Influence of CYP3A5 6986A > G and ABCB1 3435C > T Polymorphisms on Adverse Events Associated With Tacrolimus in Jordanian Pediatric Renal Patients
    Authors: S.K.B. Sy, R.P. Singh, S. Shilbayeh, R. Zmeili, D. Conrado, H. Derendorf
    Year: 2013
    Citations: 9

  • Title: The anti-clot treatment scale (ACTS): validation of the translated Arabic version among patients undergoing warfarin therapy in Saudi Arabia
    Authors: S.A.R. Shilbayeh, A.A. Ibrahim
    Year: 2020
    Citations: 7

  • Title: Patient experience with an educational mobile health application: A pilot study on usability and feasibility in a Saudi population
    Authors: I.S.A. Shilbayeh, S.A. Shilbayeh
    Year: 2020
    Citations: 7

🏁 Conclusion

The Clinical Pharmacy Award is more than a recognition—it’s a platform to celebrate innovation, dedication, and impact in pharmaceutical care. By honoring professionals who excel in clinical practice, education, and research, this award promotes advancement in healthcare delivery and encourages the adoption of evidence-based, patient-centered approaches. Whether you’re an academic, clinician, or researcher, this is your opportunity to showcase your contributions to the evolving field of pharmacy. Apply now, inspire others, and join a distinguished network of leaders shaping the future of clinical pharmacy.

Baby Rabiya Parveen | Pharmaceutical Chemistry | Best Researcher Award

Published on by World Top Scientists

Ms. Baby Rabiya Parveen | Pharmaceutical Chemistry | Best Researcher Award

Associate Professor, S.D. College of Pharmacy & Vocational Studies, Muzaffarnagar, India

Dr. Baby Rabiya Parveen is a dedicated researcher currently pursuing a PhD in Pharmaceutical Chemistry from IFTM University, Moradabad. With a Master’s in Pharmaceutical Chemistry and a Bachelor’s in Pharmacy, both from S.D. College of Pharmacy, her academic journey has been marked by excellence and a commitment to advancing pharmaceutical sciences. Her research interests span the synthesis of novel pharmaceutical compounds and their biological evaluations, contributing significantly to her field. 🌟

Publication Profile

ORCID

Strengths for the Award:

  1. Extensive Educational Background: Rabiya Parveen is pursuing a PhD in Pharmaceutical Chemistry and holds both a Master’s and Bachelor’s degree in Pharmaceutical Chemistry with impressive academic performance.
  2. Diverse Workshop Participation: She has actively participated in numerous workshops and faculty development programs covering a wide range of topics relevant to pharmaceutical research, including intellectual property rights, drug regulatory affairs, and biotechnological applications.
  3. Research Contributions: Rabiya has contributed significantly to the field with multiple research papers on topics such as novel oxazine derivatives, antimicrobial agents, and drug synthesis. Her work on molecular docking and synthesis of new compounds demonstrates a strong commitment to advancing pharmaceutical science.
  4. Conference Presentations: She has presented her research at several national and international conferences, showcasing her work to a broader scientific audience and contributing to the dissemination of knowledge in the field.
  5. Industrial Experience: Her industrial training at Deepali Pharmaceuticals adds practical experience to her academic achievements, enhancing her understanding of real-world applications of her research.
  6. Book Chapters: Rabiya has contributed chapters to books on advanced topics like metallic nanoparticles and ghee standards, reflecting her expertise and ability to communicate complex concepts.

Areas for Improvement:

  1. Publication Record: While Rabiya has a commendable list of research papers, increasing the number of high-impact publications in top-tier journals could further strengthen her research profile.
  2. Research Impact: Demonstrating the practical impact of her research on pharmaceutical practice or policy could provide more evidence of her work’s significance.
  3. Collaborative Research: Engaging in collaborative projects with researchers from other institutions or industries might enhance the scope and applicability of her research.
  4. Grants and Funding: Securing research grants and funding could support more extensive studies and increase her visibility in the research community.

Education

Dr. Baby Rabiya Parveen is pursuing a PhD in Pharmaceutical Chemistry from IFTM University, Moradabad. She completed her Master of Pharmacy in Pharmaceutical Chemistry with honors from S.D. College of Pharmacy & Vocational Studies, Muzaffarnagar, and her Bachelor of Pharmacy from the same institution. Her academic background also includes a high distinction in both Intermediate and High School studies. 📚

Experience

Dr. Parveen has gained practical experience through a 45-day industrial training at Deepali Pharmaceuticals, Muzaffarnagar, where she applied her theoretical knowledge to real-world pharmaceutical practices. This hands-on experience complements her extensive academic training and research work. 🏭

Research Focus

Dr. Parveen’s research primarily focuses on the synthesis of novel pharmaceutical compounds and their pharmacological activities. Her work includes the development of new oxazine derivatives, Schiff bases, and isoxazole compounds, with a keen interest in their anti-inflammatory, antimicrobial, and anxiolytic activities. Her research contributes to the development of new therapeutic agents. 🔬

Awards and Honours

Dr. Parveen has been recognized for her academic and research achievements through various awards and honors. Her contributions to pharmaceutical sciences have been acknowledged in multiple conferences and workshops, reflecting her commitment to advancing the field. 🏆

Publications

“Synthesis of some new 3-[5-(substituted-phenyl)-[1,3,4]oxadiazole-2-yl]-1-napthalen-2-yl-propan-1-one” – Published in [Journal Name, Year].

“Synthesis and Biological Evaluation of Some New Amide Derivatives of Sulfonamide” – Published in [Journal Name, Year].

“Synthesis and biological evaluation of some new Schiff base 1,2,4-Triazole Derivatives” – Published in [Journal Name, Year].

“A Short Review on Sulfonamides with Antimicrobial Activity” – Published in [Journal Name, Year].

“A Short Review on Synthesis and Pharmacological Activity of Isoxazole” – Published in [Journal Name, Year].

Conclusion:

Baby Rabiya Parveen is a strong candidate for the Research for Best Researcher Award due to her solid educational background, active participation in professional development, significant research contributions, and industrial experience. Her diverse expertise and dedication to advancing pharmaceutical sciences are commendable. Addressing the areas for improvement, particularly in increasing high-impact publications and demonstrating the practical impact of her research, could further solidify her position as a leading researcher in her field.

 

RAJWINDER KAUR | MEDICINAL CHEMISTRY | Best Researcher Award

Published on by World Top Scientists

Dr. RAJWINDER KAUR | MEDICINAL CHEMISTRY | Best Researcher Award

PROFESSOR, CHITKARA UNIVERSITY, India

Dr. Rajwinder Kaur is an esteemed professor and researcher with over 16 years of experience in pharmaceutical education and research. She currently holds the position of Assistant Dean for the PharmD Program at Chitkara University, Rajpura. Her career is marked by significant contributions to the field of pharmaceutical chemistry, focusing on drug design and development. Dr. Kaur has received numerous awards and honors for her dedication and excellence in the field, including the Young Scientist Award and the Best Teacher Award.

Education 🎓

Dr. Rajwinder Kaur has an extensive academic background in pharmaceutical sciences. She completed her B. Pharm with distinction from A.S.B.A.S.J.S.M. College of Pharmacy in 2004 and her M. Pharm from Rajiv Academy for Pharmacy in 2007. She earned her Ph.D. in Pharmaceutical Chemistry from Panjab University, Chandigarh in 2014. Additionally, she holds multiple postgraduate diplomas, including in Clinical Trial, Research & Administration, and Guidance and Counselling.

Professional Experience 🏢

Dr. Kaur’s professional journey spans various prestigious institutions. She began as a lecturer at Polytechnic Institute for Women, Ropar, and later joined Panjab University as a Project Fellow and CSIR-SRF. She has also served as a Women Scientist under the DST-WOS(A) scheme. Her recent roles include Assistant Professor at Chandigarh University, and Associate Professor, Professor, and Assistant Dean at Chitkara University.

Research Interests 🔬

Dr. Kaur’s research interests lie in computer-aided drug design and the discovery of new chemical entities. Her focus areas include the development of novel adenosine receptor ligands, anti-inflammatory agents, antiasthmatics, and neuroprotective compounds. She also explores natural products for treating diseases like dengue and cerebral ischemic injury.

Awards 🏆

Dr. Kaur has been recognized with several prestigious awards, including:

  • Young Scientist Award (Women in Pharmaceutical Sciences) at Chitkara University in 2023
  • Best Teacher Award by Chandigarh University in 2016
  • Dr. Harpal Singh Buttar and Harinder Kaur Buttar Young Scientist Award in 2013
  • DST Women Scientist (WOS-A) by the Department of Science and Technology, India

Profile 🌐

Google Scholar Profile: Dr. Rajwinder Kaur

Publications Top Notes 📚

Target protein degradation by protacs: A budding cancer treatment strategy. Pharmacology & Therapeutics, 2023. DOI: 10.1016/j.pharmthera.2023.108525

Evolving Advances in the Cosmetic Use of Probiotics and Postbiotics: Health, Regulatory and Marketing Aspects. Curr Pharm Biotechnol, 2023. DOI: 10.2174/1389201024666230703115732

Combating Microbial Infections Using Metal-Based Nanoparticles as Potential Therapeutic Alternatives. Antibiotics, 2023. DOI: 10.3390/antibiotics12050909

Antibiotics in Paediatrics: A Boon or a Bane? Anti-Infective Agents, 2023, 21(2), 1-17.

Synthesis and Pharmacological Evaluation of Promising Coumarin Methyl ester/di/tri/terta Peptide Derivatives. ECS Transactions, 2022, 107(1), 6747–6761.

In Silico Evaluation of Reserpine as Potential Anti-Candidal Agent. J. Pharm. Tech. Res. Management, 2021, 9(1), 1–5.

Importance of Pharmacovigilance in Ayurveda. J. Pharm. Tech. Res. Management, 2021, 9(2), 87–97.

Targeting natural products against SARS-CoV-2. Environmental Science and Pollution Research, 2022, 29(28), 42404–42432.